Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Bioequivalence Study of PP3M in Patients With Schizophrenia [NA]
A clinical trial update describing a bioequivalence study of PP3M in patients with schizophrenia, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia [NA]
A clinical trial sponsored by Centre Psychothérapique de Nancy is studying sensory and cognitive predictions and their disruptions in schizo…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: EEG and Behavioral Correlates of Temporal Prediction in the Tactile Modality in Schizophrenia [NA]
This ClinicalTrials.gov entry reports a study examining EEG and behavioral markers of temporal prediction in the tactile modality for schizo…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia [Phase 2]
This clinical trial update describes a Phase 2 study evaluating a combination of NMDA-enhancing and anti-inflammatory therapies for ultra-re…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Monotherapy of an NMDA Enhancer for Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating a monotherapy NMDA receptor enhancer for schizophrenia is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Cue-based Intervention in Prospective Memory and Medication Adherence. [NA]
This clinical trial is investigating a cue-based intervention to improve prospective memory and medication adherence in schizophrenia. The s…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer [Phase 2]
A Phase 2 clinical trial evaluating an NMDA enhancer for early intervention in prodromal schizophrenia, currently recruiting at China Medica…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders [NA]
This clinical trial update indicates that a study evaluating transcranial magnetic stimulation for negative symptoms in schizophrenia is cur…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia [Phase 2]
Phase 2 clinical trial investigating dual modulation of sigma-1 and NMDA receptors for schizophrenia, currently recruiting.
-
EMA approval · 2026-03-23EMA Authorised: Rxulti (brexpiprazole) — Otsuka Pharmaceutical Netherlands B.V.
The European Medicines Agency authorised Rxulti (brexpiprazole) for schizophrenia in the European Union. The marketing authorisation holder …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Digital Strategies to Advance Help-Seeking - Aim 3 [NA]
A Columbia University trial update describes Aim 3 of a digital strategy study to promote help-seeking among individuals at clinical high ri…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Brain Imaging of Cognition Inn Schizophrenia and Depression
A recruiting clinical trial at The Royal Ottawa Mental Health Centre is studying brain imaging and cognition in individuals with schizophren…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder [NA]
This clinical trial investigates improving health literacy among patients with schizophrenia spectrum disorders, and it is currently not yet…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms in Treatment-Resistant Schizophrenia: A Pilot Study [EARLY_Phase 1]
A Phase 1 pilot study assessing the safety and feasibility of nasal delivery of exosomes derived from human dental follicle mesenchymal stem…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia [Phase 1]
This entry outlines a Phase 1 clinical trial to evaluate the pharmacokinetics, safety, and tolerability of AX251 LAI in patients with schizo…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia [Phase 2]
A Phase 2 clinical trial update describing the safety, tolerability, and treatment response study of GXV813 in hospitalized adults with schi…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating cromoglicate as adjunctive therapy for outpatients with schizophrenia, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Peer-led Psycho-education for Schizophrenia [NA]
The clinical trial evaluating peer-led psycho-education for schizophrenia has completed.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Cerebellar Stimulation and Cognitive Control [NA]
A clinical trial update notes that a cerebellar stimulation study assessing cognitive control is currently recruiting, with conditions inclu…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Cognitive Effects of tDCS and tRNS in Schizophrenia [NA]
A completed study evaluating the cognitive effects of non-invasive brain stimulation using tDCS and tRNS in schizophrenia with cognitive imp…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders [NA]
A completed clinical trial update reports results for iTEST, studying introspective accuracy as a novel target to improve functioning in sch…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders
This clinical trial update describes a study evaluating ultra-high-field MRI biomarkers combined with visual perception assessment to improv…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Arts-based Social Prescribing for Mental Health [NA]
A completed clinical trial evaluating arts-based social prescribing as a non-pharmacological approach to improving mental health outcomes.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention [NA]
A completed clinical trial evaluating an SMS-based transition support from the Emergency Department to Early Psychosis Intervention.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Tolerability of MDMA in Schizophrenia [Phase 1, Phase 2]
This clinical trial update describes an ongoing Phase 1/Phase 2 study evaluating the tolerability of MDMA in adults with schizophrenia, curr…